Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marona-Lewicka

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pharmacology, Biochemistry, and Behavior|February 1, 1987
The effect of chronic imipramine and electroconvulsive shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamineL Antkiewicz-Michaluk, J Michaluk, A Rokosz-Pelc, et al.
Pharmacology, Biochemistry, and Behavior|March 25, 1998
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potentialN V Cozzi, S Frescas, D Marona-Lewicka, et al.
Journal of Medicinal Chemistry|March 17, 1995
Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanesA P Monte, D Marona-Lewicka, A Kanthasamy, et al.
Journal of Medicinal Chemistry|April 4, 1998
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)M A Parker, D Marona-Lewicka, D Kurrasch, et al.
Journal of Medicinal Chemistry|October 9, 1999
Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chainM Gerasimov, D Marona-Lewicka, D M Kurrasch-Orbaugh, et al.
Journal of Medicinal Chemistry|December 19, 1998
A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptorM A Parker, D Marona-Lewicka, V L Lucaites, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1992
[Experimental model of depression: neurochemical changes and the effects of imipramine and citalopram]N N Kudriavtseva, I V Bakshtanovskaia, I A Madorskaia, et al.
Journal of Medicinal Chemistry|March 26, 1999
Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamineJ B Blair, D Marona-Lewicka, A Kanthasamy, et al.
Journal of Medicinal Chemistry|July 19, 1996
Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groupsA P Monte, D Marona-Lewicka, M A Parker, et al.
Journal of Medicinal Chemistry|December 9, 1994
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonistD E Nichols, S Frescas, D Marona-Lewicka, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|February 1, 1987
The effect of chronic imipramine and electroconvulsive shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamineL Antkiewicz-Michaluk, J Michaluk, A Rokosz-Pelc, et al.
Pharmacology, Biochemistry, and Behavior|March 25, 1998
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potentialN V Cozzi, S Frescas, D Marona-Lewicka, et al.
Journal of Medicinal Chemistry|March 17, 1995
Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanesA P Monte, D Marona-Lewicka, A Kanthasamy, et al.
Journal of Medicinal Chemistry|April 4, 1998
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)M A Parker, D Marona-Lewicka, D Kurrasch, et al.
Journal of Medicinal Chemistry|October 9, 1999
Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chainM Gerasimov, D Marona-Lewicka, D M Kurrasch-Orbaugh, et al.
Journal of Medicinal Chemistry|December 19, 1998
A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptorM A Parker, D Marona-Lewicka, V L Lucaites, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1992
[Experimental model of depression: neurochemical changes and the effects of imipramine and citalopram]N N Kudriavtseva, I V Bakshtanovskaia, I A Madorskaia, et al.
Journal of Medicinal Chemistry|March 26, 1999
Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamineJ B Blair, D Marona-Lewicka, A Kanthasamy, et al.
Journal of Medicinal Chemistry|July 19, 1996
Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groupsA P Monte, D Marona-Lewicka, M A Parker, et al.
Journal of Medicinal Chemistry|December 9, 1994
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonistD E Nichols, S Frescas, D Marona-Lewicka, et al.
Pageof 4